US Oncology Network Hereditary Genetics and Precision Medicine Conference 2025

Join Tempus and Ambry, a Tempus Company, to explore the early stages of our collaboration and the latest in AI-driven precision medicine. Learn about our innovative solutions, key differentiators, and see how we are advancing hereditary genetics and personalized care together.

Schedule a meeting with us→

FRI, SEP 12

12:00pm - 1:00pm CDTLIVELocation: Symphony Ballroom ABCD

Tempus & Ambry Genetics: Advancing Hereditary Cancer and Precision Medicine Testing Together

Join Dr. Jyoti Patel (Tempus) and Dr. Steven Lipkin (Ambry Genetics) as they explore how Tempus’s AI-driven platform and Ambry’s hereditary cancer expertise are advancing precision medicine. The session will highlight how their combined somatic and germline testing capabilities offer a more comprehensive view of each patient's cancer and the expanded testing access throughout their journey. Add to calendar

Steven M. Lipkin MD PhD, CMO (Ambry) Dr. Jyoti Patel, Vice President, Clinical Solutions (Tempus)

Schedule a meeting with us

We'll be in touch shortly.